Author: healthadmin

Researchers from Radboud University, Oxford University, and Cambridge University set out to test a surprising idea. Can we simply change people? expect How can I change my preference for sweet drinks? Their findings were; JNeuroscisuggests the answer is “yes”. The research team surveyed 99 healthy adults with an average age of 24. The participants were chosen because they had similar opinions about sugar and artificial sweeteners. Most people reported that they liked both about equally. But when researchers subtly changed what participants believed they were drinking, their experiences changed. When people are told that they are drinking a drink containing…

Mount Sinai ophthalmologists unveil a new surgical technique that allows eye surgeons to measure and respond to critical intraocular fluid dynamics in real time. This is an advancement that has the potential to significantly improve the accuracy and outcomes of glaucoma and other eye surgeries. The technology, called miDOC (micro-interventional Dynamic Outflow Curve), will be introduced by Sean Iantuleff, MD, MPH, professor of ophthalmology at the Icahn School of Medicine at Mount Sinai and director of ophthalmology innovation and technology at New York Eye, Ear, and Throat (NYEE) at Mount Sinai, at the prestigious Charles D. Kelman Innovator Lecture at…

While the personalized approach has dramatically improved outcomes for many patients with non-Hodgkin B-cell lymphoma (a blood cancer that develops in immune cells called B cells), the same is not true for patients with a rarer type of lymphoma that originates from immune cells called T cells. Peripheral T-cell lymphomas consist of a variety of blood cancers with unique biology, and survival rates vary widely. Dr. Jia Luan, a lymphoma expert and professor of clinical medicine at Weill Cornell Medical College, and her collaborators are working to change that. We previously thought we could treat all non-Hodgkin lymphomas with a…

Better cancer treatments depend on better treatment options. That’s why the Ontario Cancer Research Institute (OICR) is supporting four Ontario-based research teams working to develop the next generation of cancer treatments designed to more effectively destroy tumors, reduce side effects, and lower the chance of cancer recurrence. These projects target “master regulator” proteins that play a role in breast and ovarian cancers, hard-to-treat leukemias, the most aggressive forms of the most common childhood brain tumors, and many different cancers. OICR is backing these research teams by providing them with a total of $3.1 million over two years through the Cancer…

Satellite observations show that Earth’s nights are steadily getting brighter, but the trend is not uniform. Data from the VIIRS DNB instrument, covering the period 2014 to 2022, shows that global nighttime lighting is increasing by approximately 2% each year. “We’re seeing a total increase of 16% worldwide, but that doesn’t mean we’re increasing lighting everywhere,” Christopher Kaiba explained. “We found that global emissions increased by 34% in regions where lighting increased. This was offset by an 18% decrease in emissions from other regions.” These findings reveal that changes in nighttime illumination are more dynamic and localized than previously understood.…

Recent research suggests that authoritarian leaders are most likely to initiate large-scale democratic reforms when they have a special combination of impulsive optimism and rational calculation. By using mathematical models to map how political leaders handle risk and reward, this study provides evidence that paths to reform, which may seem risky in the short term, are often beneficial in the long term. The survey results are American Political Science Journal. Eugene Yu Ji, a postdoctoral researcher in cognitive science and computer science at the University of Waterloo and the Mira-Québec Institute for Artificial Intelligence, conducted the study to understand the…

Eli Lilly sold its oral GLP-1 tablet Foundayo directly to consumers through LillyDirect’s cash payment channel, as well as telehealth providers and pharmacies throughout the United States. This drug is a once-daily oral obesity treatment drug. It will be used in conjunction with a reduced-calorie diet and increased physical activity, the drugmaker said in a statement. For commercially insured patients, the pill costs just $25 a month with a savings card, and those who choose to pay out-of-pocket can get the lowest dose for $149 a month. The company says Medicare Part D users may also be able to get…

Specialty assets company Garda Therapeutics has acquired Assertio and its chemotherapy supportive care treatment Rolbedone for $125.1 million, as well as a conditional value right (CVR) for another of the company’s drugs. In connection with this transaction, Assertio sold its remaining assets to Cossette Pharmaceuticals, a New Jersey generic and branded drug manufacturer, for $35 million. These assets include Sympazan, an add-on therapy to limit seizures associated with Lennox-Gastaut syndrome, and a portfolio of branded nonsteroidal anti-inflammatory drugs (NSAIDs). Garda has also provided a non-tradable CVR relating to future milestones for Sprix, one of the drugs sold by Assertio. Sprix…

AbbVie is at the forefront of a new battle in drug companies’ long-running fight to reform the federal government’s $340 billion drug discount program, with a lawsuit challenging the definition of “patient” within the program’s framework. AbbVie, which has participated in the 340B system for 30 years, filed the lawsuit to “restore the integrity” of the drug discount program, the company said in a 72-page complaint against the Department of Health and Human Services (HHS) and its Secretary Robert F. Kennedy Jr., as well as the Health Resources and Services Administration (HRSA) and Administrator Thomas Engels. The 340B program is…

Humana has partnered with digital health company b.well Connected Health to give members easy access to their health data across multiple providers, health plans, pharmacies, and digital health apps. The partnership is in line with the Trump administration’s broader push to give patients easier access to their health information. As part of the partnership with b.well, Humana will also have real-time access to member data at the point of claims processing, securely respond to data requests from providers and other health plans, and support care coordination and quality improvement, the insurer said in an April 9 press release. B.well also…